ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > PSGL-1

PSGL-1

概要

Name:P-selectin glycoprotein ligand-1
Target Synonym:P-selectin glycoprotein ligand 1,PSGL-1,SELPLG,Selectin P Ligand,Cutaneous Lymphocyte-Associated Associated Antigen,CD162 Antigen,CD162,PSGL1,CLA
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase 2 Clinical

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
コンジュゲート:
製造番号 種類 製品説明 構造 純度 特徴
PS1-H82E4 Human Biotinylated Human PSGL-1 / CD162 Protein, His,Avitag™
PS1-H82E4-structure
PS1-H82E4-sds
PS1-H52H9 Human Human PSGL-1 / CD162 Protein, His Tag
PS1-H52H9-structure
PS1-H52H9-sds
ACRO Quality

生物活性データの一部

PS1-H52H9-BLI
Human_FcRn_Heterodimer_Protein_SPR

Human PSGL-1, His Tag (Cat. No. PS1-H52H9) immobilized on CM5 Chip can bind Human B7-H5, Fc Tag (Cat. No. B75-H5259) with an affinity constant of 0.213 μM as determined in a SPR assay (Biacore T200) (Routinely tested).

Synonym Name

PSGL1,CD162,SELPLG,Selectin P ligand

Background

P-selectin glycoprotein ligand 1 (PSGL-1) is also known as Selectin P ligand (SELPLG), CD antigen CD162. PSGL-1 is disulfide-linked homodimer which is the high affinitycounter-receptor for P-selectin on expressed on activated endothelial cells and platelets. PSGL-1 / SELPLG  interacts with P-, E- and L-selectins, through their lectin/EGF domains, is required for promoting recruitment and rolling of leukocytes. These interactions require sialyl Lewis X glycan modification but there is a differing dependence for tyrosine sulfations. Dimerization appears not to be required for P-selectin/SELP binding. PSGL-1 can interact with SNX20, MSN and SYK. PSGL-1 / SELPLG mediate the activation of SYK by SELPLG.

Clinical and Translational Updates

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
Cepeprubart SelK-2 Phase 2 Clinical Selexys Venous Thromboembolism; Asthma; Pulmonary Disease, Chronic Obstructive Details
Leiolizumab ALTB-268; AbGn-168H2; AbGn 168H2; AbGn-268 Phase 2 Clinical Altrubio Inc Colitis, Ulcerative Details
Neihulizumab AbGn-168; AbGn-168H Phase 1 Clinical Abgenomics Graft vs Host Disease; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic Details
SSGJ-617 SSGJ-617; SSGJ617; 61X; VTX-0811; 617 Phase 1 Clinical Verseau Therapeutics Inc Solid tumours Details

This web search service is supported by Google Inc.

totopphone